Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1804225Generated: November 1, 2026

(R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid → (R)-3-{4-[4-(3-ethyl-5-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one hydrochloride

https://huagongshe.com/reaction/1804225

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acidHCID 58484719—
Reactant1-(3-Ethyl-5-methylpyridin-2-yl)piperazine hydrochlorideHCID 67380857—
Product(R)-3-{4-[4-(3-ethyl-5-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one hydrochlorideHCID 6738075466.8%

Reaction Steps

By reaction and treatment in the same manner as in Example 87 and using (R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (332 mg) described in Preparation Example 37 and 1-(3-ethyl-5-methylpyridin-2-yl)piperazine hydrochloride (363 mg) described in Preparation Example 54, the title compound (446 mg) was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08354401B2
Source datasetuspto-grants-2013_01
ORD IDord-110ab60088f94dd5ab8e8c56b9700752
Source noteuspto-grants-2013_01